Clinical Trials Browser

Phase 2 × Interventional × Nasopharangeal Cancer × Clear all

NCT07392320 2026-02-06

A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

Phase 2 Recruiting

Nasopharangeal Cancer